Home > For Consumers > Aboriginal and Torres Strait Islander Health > Publications and Reporting > OATSIH Publications

OATSIH Publications

Listings on the PBS for Aboriginal and Torres Strait Islander People

This list details all PBS items that are limited for prescription to Aboriginal and Torres Strait Islander people. This is based on the 1 November 2011 Pharmaceutical Benefits Schedule.

PDF printable version: PBS items that are limited for prescription to Aboriginal and Torres Strait Islander people (PDF 476 KB)

HTML version

Item Code	Name Manner of Administration	Branch Name	Manufacturer	Max Quantity	No of Repeats
Authority Required (Streamlined) - 2354: Treatment of a fungal or yeast infection in an Aboriginal or Torres Strait Islander person
9024Y	Ketoconazole Cream 20mg per g (2%), 30g	Nizoral 2% Cream	Johnson & Johnson	1	2
9025B	Ketoconazole Shampoo 10mg per g (1%), 100mL	Nizoral 1%	Johnson & Johnson	1	1
1574W	Ketoconazole Shampoo 20mg per g (2%), 60mL	Nizoral 2%	Johnson & Johnson	1	1
9026C	Miconazole nitrate Cream 20mg per g (2%), 15g	Daktarin	Johnson & Johnson	2	3
9027D	Miconazole nitrate Cream 20mg per g (2%), 30g	Daktarin	Johnson & Johnson	1	2
9028E	Miconazole nitrate Cream 20mg per g (2%), 70g	Daktarin	Johnson & Johnson	1	1
9029F	Miconazole nitrate Powder 20mg per g (2%), 30g	Daktarin	Johnson & Johnson	1	2
9030G	Miconazole nitrate Lotion 20mg per mL (2%), 30g	Daktarin	Johnson & Johnson	1	2
9031H	Miconazole Tincture 20mg per mL (2%), 30mL	Daktarin	Johnson & Johnson	1	2
1698J	Nystatin Cream 100,000 units per g, 15g	Mycostatin	Fawns and McAllan	2	3
9160D	Terbinafine hydrochloride Cream 10mg per g (1%), 15g	Lamisil	Novartis	2	3
Authority Required (Streamlined) - 2384: Prophylaxis of thiamine deficiency in an Aboriginal or Torres Strait Islander person.
1070H	Thiamine hydrochloride Tablet 100mg	Betamin	Sanofi-Aventis	100	2
Authority Required (Streamlined) 2446: Treatment of whipworm infestation in an Aboriginal or Torres Strait Islander person. 1388: Strongyloidiasis; 3241: Treatment of hookworm infestation.
9047E	Albendazole Tablet 200mg	Zentel	GlaxoSmithKline	6	0
Authority Required Treatment of chronic suppurative otitis media in an Aboriginal or Torres Strait Islander person aged 1 month or older; Treatment of suppurative otitis media in a patient less than 18 years of age with perforation of the tympanic membrane; Treatment of chronic suppurative otitis media in a patient less than 18 years of age with a grommet in situ.
2480M	Ciprofloxacin Ear drops 3 mg per mL (0.3%), 5 mL	Ciloxan	Alcon Laboratories
Authority Required Treatment of a dermatophyte infection in an Aboriginal or Torres Strait Islander person where topical treatment has failed.
2285G	Terbinafine Tablet 250mg (as hydrochloride)	Lamisil GenRx Terbinafine Tamsil Terbihexal Terbinafine 250 Sebifin 250 Terbix-250 Terbinafine-GA Terbinafine-DRLA Tinasil	Novartis GenRx Sigma Pharmaceuticals Sandoz Pharmacor Ranbaxy Meditech Ascent Pharma Dr Reddy’s Laboratories Alphapharm	42 42 42 42 42 42 42 42 42 42	0 0 0 0 0 0 0 0 0 0
Authority Required Nicotine dependence in an Aboriginal or Torres Strait Islander person as the sole PBS-subsidised therapy Note: Only two courses of PBS-subsidised nicotine replacement therapy will be authorised per year. No applications for increased maximum quantities and/or repeats will be authorised. Benefit is improved if used in conjunction with a comprehensive support and counselling program.
9198D	Nicotine Transdermal patch releasing approx. 15mg per 16 hours	Nicorette Patch	Johnson and Johnson	28	2 per yr
Authority (Streamlined) 3136: Nasal colonisation with Staphylococcus aureaus in an Aboriginal or Torres Strait Islander person. Note: No applications for increased maximum quantities and/or repeats will be authorised.
9440W	Nasal Ointment Mupirocin Nasal ointment 20mg (as Calcium) per g (2%), 3 g	Bactroban	GlaxoSmithKline	1	0

All information in this publication is correct as of November 2011

If you are unable to download the PDF please email OATSIH enquiries or phone: 02 6289 5291.

The Pharmaceutical Benefits Schedule is updated on the first of every month. For more information on the Pharmaceutical Benefits Schedule view the following link: www.pbs.gov.au